Manufacturer of Controlled Substances; Notice of Registration; Johnson Matthey Pharma Services, 24988 [2012-10051]
Download as PDF
<![CDATA[
24988
Federal Register / Vol. 77, No. 81 / Thursday, April 26, 2012 / Notices
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823(a),
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: April 17, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
the basic classes of controlled
substances listed.
Dated: April 17, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
Drug Enforcement Administration
[FR Doc. 2012–10041 Filed 4–25–12; 8:45 am]
Drug Enforcement Administration
BILLING CODE 4410–09–P
Manufacturer of Controlled
Substances; Notice of Registration;
Johnson Matthey Pharma Services
Manufacturer of Controlled
Substances; Notice of Registration;
ISP Freetown Fine Chemicals
By Notice dated October 8, 2010, and
published in the Federal Register on
October 20, 2010, 75 FR 64746, ISP
Freetown Fine Chemicals, 238 South
Main Street, Assonet, Massachusetts
02702, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
Drug
Schedule
tkelley on DSK3SPTVN1PROD with NOTICES
2,5–Dimethoxyamphetamine
(7396).
Amphetamine (1100) ..................
Phenylacetone (8501) ................
I
II
II
The company plans to manufacture
bulk API, for distribution to its
customers. The bulk
2,5-Dimethoxyamphetamine will be
used for conversion into non-controlled
substances.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of ISP
Freetown Fine Chemicals, to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time. DEA has
investigated ISP Freetown Fine
Chemicals to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823(a),
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
VerDate Mar<15>2010
17:51 Apr 25, 2012
Jkt 226001
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[FR Doc. 2012–10051 Filed 4–25–12; 8:45 am]
[FR Doc. 2012–10055 Filed 4–25–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Dated: April 17, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
By Notice dated December 5, 2011,
and published in the Federal Register
on December 12, 2011, 76 FR 77257,
Johnson Matthey Pharma Services, 70
Flagship Drive, North Andover,
Massachusetts 01845, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the following
basic classes of controlled substances:
Drug
Schedule
Amphetamine (1100) ....................
Methylphenidate (1724) ................
Hydrocodone (9193) .....................
II
II
II
The company plans to utilize this
facility to manufacture small quantities
of the listed controlled substances in
bulk and to conduct analytical testing in
support of the company’s primary
manufacturing facility in West Deptford,
New Jersey. The controlled substances
manufactured in bulk at this facility will
be distributed to the company’s
customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Johnson Matthey Pharma Services to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time. DEA has
investigated Johnson Matthey Pharma
Services to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823(a),
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
PO 00000
Frm 00064
Fmt 4703
Sfmt 9990
Manufacturer of Controlled
Substances; Notice of Registration;
Johnson Matthey Inc.
By Notice dated November 21, 2011,
and published in the Federal Register
on November 29, 2011, 76 FR 73679,
Johnson Matthey Inc., Pharmaceuticals
Materials, 900 River Road,
Conshohocken, Pennsylvania 19428,
made application by letter to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
Drug
Diphenoxylate (9170) ...................
Meperidine (9230) ........................
Methadone (9250) ........................
Methadone Intermediate (9254) ...
Schedule
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution and sale to its
customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Johnson Matthey Inc. to manufacture
the listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Johnson Matthey Inc. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823(a),
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: April 17, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–10050 Filed 4–25–12; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\26APN1.SGM
26APN1
]]>Agencies
[Federal Register Volume 77, Number 81 (Thursday, April 26, 2012)]
[Notices]
[Page 24988]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-10051]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration;
Johnson Matthey Pharma Services
By Notice dated December 5, 2011, and published in the Federal
Register on December 12, 2011, 76 FR 77257, Johnson Matthey Pharma
Services, 70 Flagship Drive, North Andover, Massachusetts 01845, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of the following basic classes of
controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Amphetamine (1100)......................... II
Methylphenidate (1724)..................... II
Hydrocodone (9193)......................... II
------------------------------------------------------------------------
The company plans to utilize this facility to manufacture small
quantities of the listed controlled substances in bulk and to conduct
analytical testing in support of the company's primary manufacturing
facility in West Deptford, New Jersey. The controlled substances
manufactured in bulk at this facility will be distributed to the
company's customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Johnson Matthey Pharma Services to manufacture the listed basic classes
of controlled substances is consistent with the public interest at this
time. DEA has investigated Johnson Matthey Pharma Services to ensure
that the company's registration is consistent with the public interest.
The investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance
with 21 CFR 1301.33, the above named company is granted registration as
a bulk manufacturer of the basic classes of controlled substances
listed.
Dated: April 17, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-10051 Filed 4-25-12; 8:45 am]
BILLING CODE 4410-09-P
